Endpoints News 2026년 3월 28일 #AAD26: Tanabe’s Phase 3 win for drug targeting rare diseases that cause pain upon light exposure
Endpoints News 2026년 3월 28일 A week of bolt-on deals; Wave crashes on obesity data; Sanofi partners with TCE startup; and more
Endpoints News 2026년 3월 27일 CHMP recommends subcutaneous form of Sanofi's Sarclisa and four new drugs
Endpoints News 2026년 3월 27일 AnaptysBio spins out biotech operations; Affibody's data in hidradenitis suppurativa
Endpoints News 2026년 3월 27일 AstraZeneca’s in vivo CAR-T led to early responses, but one death in China trial
Endpoints News 2026년 3월 27일 Novartis to spend up to $2B on Excellergy and its next-gen Xolair candidate
Endpoints News 2026년 3월 27일 AstraZeneca’s COPD antibody gets Phase 3 wins in broader-than-expected population
Endpoints News 2026년 3월 26일 Biopharma industry pushes back on FDA's 'America First' user fee proposals